Background: Phosphoinositide 3-kinase (PI 3-kinase) activity is required for mitogenic signaling and for secretory responses. Cell activation is presumed to cause the translocation of PI 3-kinase from the cytosol to the plasma membrane where the kinase interacts with its substrate phosphatidylinositol (4,5)-bisphosphate. Thus, a membrane-targeted and therefore constitutively active kinase could help elucidate the role of PI 3-kinase in intracellular signaling.
Background
Phosphoinositide 3-kinase (PI 3-kinase) selectively phosphorylates the 3-OH position of phosphoinositides. The enzyme has been implicated in mitogenic signal transduction induced by growth factors [1] [2] [3] [4] [5] [6] and in the regulated exocytosis of secretory organelles [7] [8] [9] [10] . In resting cells, the majority of PI 3-kinase is associated with the cytosol, from where it has been purified as highly active enzyme [10] [11] [12] . Interaction of the cytosolic protein with cellular membranes has been suggested to be necessary for signal transduction initiated by receptor agonists. Stimulation of cells with platelet-derived growth factor (PDGF) causes autophosphorylation of tyrosine residues of the cytoplasmic domain of the PDGF receptor, which serve as docking sites for proteins containing Src homology 2 (SH2) domains [13] . It is assumed that PI 3-kinase (p85/p110) is recruited to the plasma membrane by the SH2 domains of p85 [6, 13] . The receptor-associated kinase is then in close vicinity with its substrate, phosphatidylinositol (4, 5) bisphosphate (PI(4,5)-P 2 ) and generates phosphatidylinositol (3, 4, 5) trisphosphate (PI(3,4,5)-P 3 ) [1] . Interactions between proteins and membranes can be accomplished by attaching lipid moieties to amino-acid sequences that contain signals for myristoylation or farnesylation [14] [15] [16] . Fusion of such consensus sequences to otherwise cytosolic proteins has been used to generate membrane-associated proteins and to study their stimulus-independent roles in signal transduction [17, 18] .
The serine/threonine protein kinase B (PKB, also known as Akt/RAC [19] ) phosphorylates glycogen synthase kinase-3, an enzyme which is involved in the regulation of several physiological processes, including transcription and glycogen and protein synthesis [20] . Activation of PKB by growth factors is dependent on PI 3-kinase [20] [21] [22] . Pretreatment of cells with the specific PI 3-kinase inhibitor wortmannin [8, 10] , or mutation of tyrosine residues 740 and 751 of the PDGF receptor (the binding sites for the SH2 domains of p85 [13] ) blocks the activation of PKB [20, 21, 23] .
The NADPH oxidase of phagocytes is rapidly assembled at the plasma membrane upon stimulation with G-proteincoupled receptor agonists [24] . The assembly is accompanied by the multiple phosphorylation of the cytosolic factor p47 phox [25, 26] . Several protein kinases -including ERK (extracellular signal-regulated kinase; [27, 28] ), protein kinase C [28, 29] , protein kinase A [28, 30] and p21 rac -activated kinase (PAK; [31] ) -have been suggested to phosphorylate p47 phox at distinct sites. PI 3-kinase has also been implicated in the regulation of ERKs; [2, 4, 32, 33] and the activation of p21 rac [34] . Previous work has shown that wortmannin inhibits the activation of the NADPH oxidase by G-protein-coupled receptor agonists [10, 35] .
We show here that expression of a membrane-targeted PI 3-kinase causes constitutively elevated PI(3,4,5)-P 3 levels in the corresponding transfectants. We found that the outcome of the elevated PI(3,4,5)-P 3 levels is the stimulusindependent activation of PKB and a decrease in the basal activity of ERKs. In addition, in the monoblastic phagocyte cell line GM-1 [36] , the elevated PI(3,4,5)-P 3 levels correlate with an enhanced basal phosphorylation of p47 phox .
Results and discussion
In order to study the role of PI 3-kinase in signal transduction, we introduced a plasmid encoding a constitutively active kinase that contained the membrane-targeting sequence of Ha-Ras [16] into mammalian cells. The CAAX motif (where C is cysteine, A is generally an aliphatic amino acid and X is any amino acid) at the carboxyl terminus of Ras-like GTPases has been found to determine the farnesylation of proteins. We therefore fused 18 amino acids from the carboxyl terminus of Ha-Ras (NPPDESGPGCMSCKCVLS; the CAAX sequence is underlined) which specify farnesylation and palmitoylation [16, 18] to the carboxyl terminus of human p110␣ (the catalytic subunit of PI 3-kinase) tagged with a hemagglutinin (HA) epitope to produce the construct designated HA-p110CAAX. Membrane and cytosol fractions were prepared from the monoblastic cell line GM-1 [36] and from GM-1 cells transfected with HA-p110CAAX (GM-128 cells). Western blot analysis using antibodies directed against p85, the regulatory subunit of PI 3-kinase (Fig. 1a) , revealed that more than 90 % of the total PI 3-kinase resided in the cytosol, and only a minor portion was membrane-associated (Fig. 1a, left panel) . The marginal increase of membrane-associated PI 3-kinase in GM-128 cells suggests a moderate expression of membrane-targeted PI 3-kinase (see below). By contrast, anti-HA immunoprecipitation experiments revealed that about 50 % of the p85-HA-p110CAAX PI 3-kinase was membrane-associated (Fig. 1a, right panel) . The amount of p85 recovered in the anti-HA immunoprecipitates was small compared with the total p85 precipitated with anti-p85 antibodies from identical fractions.
Activity measurements of anti-p85 immunoprecipitates from parental and GM-128 cells confirmed that more than 95 % of total PI 3-kinase resided in the cytosol. However, selective immunoprecipitation of the membrane-targeted HA-tagged enzyme revealed that more than 50 % of the PI 3-kinase activity was membrane-associated (Fig. 1b) . The PI 3-kinase activity which was immunoprecipitated 
with anti-p85 antibodies was similar in GM-1 and GM-128 cells (data not shown). Together with the results shown in Figure 1 , this observation indicates that the expression of HA-p110CAAX does not cause a substantial increase in the total PI 3-kinase pool. Accordingly, the expression of membrane-targeted PI 3-kinase in GM-128 cells appeared not to affect the cytosol-membrane distribution of the total PI 3-kinase activity (as assessed in anti-p85 immunoprecipitates).
We measured the PI 3-kinase activity in Saccharomyces cerevisiae cells expressing the wild-type p85-HA-p110 and p85-HA-p110CAAX constructs. Similar activities were found in anti-p85 and anti-HA immunoprecipitates, suggesting that the lipid anchor had no effect on the catalytic activity (data not shown).
Cytosol and membrane fractions of NIH-3T3 fibroblasts transiently transfected with wild type HA-p110 and with HA-p110CAAX were assayed for PI 3-kinase activity. We measured the total kinase activity in both subcellular compartments in anti-p85 immunoprecipitates, and confirmed the prominent cytosolic location of the endogenous enzyme. In contrast, about 70 % of anti-HA-precipitable PI 3-kinase activity was recovered from the cytosol of cells expressing HA-p110, whereas in cells expressing HA-p110CAAX, about 75 % of the kinase activity was membrane-associated (Fig. 1c) . A similar distribution was found in subcellular fractions prepared from S. cerevisiae co-transformed with p85 and either of the two p110 constructs (data not shown). Thus, membrane-targeted HA-p110CAAX preferentially localizes to cellular membranes and confers PI 3-kinase activity. Figure 2 shows that membrane-targeted PI 3-kinase constitutively increased the cellular content of PI(3,4,5)-P 3 in serum-starved unstimulated GM-128 cells. The twofold increase in the PI(3,4,5)-P 3 content of the transfectants corresponds to the moderate expression of the membrane-targeted PI 3-kinase. In resting cells, the predominant phosphoinositide is PI(4,5)-P 2 , whereas the content of 3-phosphorylated phosphoinositides is marginal [37, 38] . Comparison of the levels of PI(3,4,5)-P 3 with those of PI(4,5)-P 2 showed that the PI(4,5)-P 2 concentrations were similar in parental and transfected lines (data not shown), and confirmed the small but significant Concentration of NaH (p < 0.00001) constitutively elevated PI(3,4,5)-P 3 content in GM-128 cells (Fig. 2b,e) . High performance liquid chromatography (HPLC) analysis of glycerophosphoinositides prepared from GM-1 and GM-128 cells confirmed the two-fold increase in the level of PI(3,4,5)-P 3 in resting p110CAAX transfectants (Fig. 2f) . Serum stimulation induced a similar rise in the PI(3,4,5)-P 3 content of untransfected and HA-p110CAAX-transfected GM-1 cells (Fig. 2a) . The net increase was comparable in both cell types (Fig. 2d) , but there was still a higher level of PI(3,4,5)-P 3 in cells transfected with HA-p110CAAX (Fig.  2a,c,e) ; this indicates that the membrane-bound HA-p110CAAX may not be activated by serum stimulation. Previous studies have shown that, upon stimulation, only a minor fraction of the total PI 3-kinase is recruited to the membrane [38] . Thus the (low) expression of HAp110CAAX correlates with the small but consistently elevated levels of PI(3,4,5)-P 3 in GM-128 cells. The increment in PI(3,4,5)-P 3 caused by the expression of membrane-targeted PI 3-kinase is comparable to the serum-stimulated PI(3,4,5)-P 3 formation in parental cells, and is presumably sufficient to activate downstream effectors (see below).
Growth factors activate protein kinase B (PKB) in a wortmannin-sensitive manner; this activation correlates with the serine and threonine phosphorylation of PKB, and can be detected by the reduced mobility of the modified protein in SDS-PAGE gels [20, 21, 39] . Western blot analysis (Fig.  3a) showed that expression of the membrane-targeted PI 3-kinase in GM-128 cells led to the constitutive activation of PKB which resulted in its retarded migration during electrophoresis. Figure 3a also shows that PKB was activated upon stimulation with serum, and that the activation was repressed if the cells were treated with wortmannin.
Mutation of an arginine residue at position 916 of the conserved kinase motif (the ATP-binding site, DRHNSN) to 
Expression of membrane-targeted PI 3-kinase results in the constitutive activation of PKB. (a) Mobility-shift assay of PKB activation. Serumstarved GM-1 and GM-128 cells were treated for 15 min with 100 nM wortmannin or medium, and then stimulated with 10 % FCS for 20 min. The cells were then lysed and PKB was immunoprecipitated. Stimulation coincided with a decreased mobility of PKB (filled arrowheads) [39] . Wortmannin treatment inhibited both constitutive and stimulated PKB activation. (b) PKB activity in transiently transfected NIH-3T3 fibroblasts. NIH-3T3 cells were transfected with wild-type HA-tagged p110␣ (HA-p110), HA-p110CAAX, inactive p110␣ carrying a point mutation (R916P) in the ATP-binding site [40] (HA-p110 R916P ) or inactive membrane-targeted p110 (HA-p110CAAX R916P ). Open bars to the right show data from cells transfected with empty vector (mock) or from untreated cells (control).
The endogenous PKB activity (mean of three independent determinations ± SD) was slightly elevated in cells transfected with the construct expressing wild-type p110, but markedly elevated in cells expressing the membrane-targeted PI 3-kinase. (c) Effect of membrane-targeted PI 3-kinase on the activation of ERK. The activation of ERK-1 (p44) and ERK-2 (p42) results in their decreased mobilities on SDS-PAGE [59] , and is detected on western blots using anti-ERK-1 and anti-ERK-2 antibodies. In resting (serum-starved) GM-1 cells a weak activation of both ERK-1 and ERK-2 is observed, which is almost completely repressed in GM-128 cells. Stimulation of GM-1 cells with 10 % FCS for 5 min resulted in a marked mobility shift (filled arrow heads) which was only marginal in the corresponding GM-128 cells. In contrast, stimulation of both GM-1 and GM-128 cells with 100 M ATP for 2 min activates ERK-1 and ERK-2.
a proline abolishes the catalytic activity of p110␣ [40] . Wild-type HA-p110, HA-p110 R916P , HA-p110CAAX and HA-p110CAAX R916P constructs were transiently expressed in NIH-3T3 fibroblasts and the effect on PKB activity was determined. Kinase assays (Fig. 3b) proved that transfection with catalytically active membrane-targeted HA-p110CAAX caused a 4-5-fold activation of PKB, whereas wild-type HA-p110 caused only a marginal (2-fold) activation.
A role for PI 3-kinase in the activation of the mitogen-activated kinases ERK-1 and ERK-2 initiated by growth factors and agonists of G-protein-coupled receptors has been discussed [33, [41] [42] [43] . By contrast, in serum-stimulated andstarved GM-128 cells, the activation of ERK-1 and ERK-2 appeared to be downregulated by the membrane-targeted PI 3-kinase, as measured by a gel-retardation assay (Fig.  3c) . This observation is in line with the recent finding that PI(3,4,5)-P 3 formation can disrupt the interaction between p85 SH2 domains and tyrosine-phosphorylated growth factor receptors [6] . In contrast to growth factor receptors, G-protein-coupled receptors activate the Ras-Raf-ERK pathway through the ␤␥ subunits of heterotrimeric G-proteins [44] [45] [46] . When GM-1 cells (which express G-proteincoupled ATP receptors at the plasma membrane; S.A.D. and M.T., unpublished results) were stimulated with ATP, we found that the membrane-targeted PI 3-kinase did not interfere with ERK activation (Fig. 3c) . Taken together, these results suggest that, in the monoblastic GM-1 cells, PI 3-kinase does not activate ERKs.
Activation of the phagocyte respiratory burst by chemotactic agonists is inhibited by wortmannin and requires the assembly of the NADPH oxidase from membrane and cytosolic components. Studies with phagocytes from patients with chronic granulomatous disease unequivocally demonstrated that, in addition to the small GTPase Rac, p47 phox and p67 phox are soluble components of the NADPH oxidase [47] [48] [49] . A role for PI 3-kinase in the activation of Rac has been suggested [34] , and it has recently been proposed that PAK phosphorylates p47 phox [31] . It was also shown that phosphorylation of p47 phox in neutrophils stimulated with the fMet-Leu-Phe peptide is partially sensitive to wortmannin or LY294002, another selective inhibitor of PI 3-kinase [50] . As the monoblastic phagocyte line GM-1 expresses p47 phox , we investigated whether the membrane-targeting of PI 3-kinase results in the constitutive phosphorylation of p47 phox . The results in Figure 4 show that basal phosphorylation of p47 phox was enhanced in cells expressing HA-p110CAAX, and that the enhanced phosphorylation was repressed by wortmannin. However, upon stimulation of phagocytes, p47 phox is phosphorylated at several sites [28] ; thus the precise role of the wortmannin-sensitive PI 3-kinasemediated phosphorylation of p47 phox in NADPH oxidase activation needs to be refined.
Conclusions
The role of PI 3-kinase in signal transduction is poorly understood. Its major substrate, PI(4,5)-P 2 , is presumably membrane-associated, but enzyme with high catalytic activity is mainly localized in the cytosol in several tissues [10, 12, 51] . A chimeric protein consisting of the inter-SH2 domain of p85 fused to the amino terminus of p110 apparently mediates growth factor-independent signaling when expressed in fibroblasts [5] . However, it is not clear how this chimeric kinase is recruited to cellular membranes and how it interacts with its presumed substrate, PI(4,5)-P 2 . We have now fused the farnesylation signal of Ha-Ras to p110 in order to position the enzyme at cellular membranes. Targeting of PI 3-kinase to the site of its preferred substrate led to constitutive stimulus-independent enhanced catalysis and initiated different classes of signaltransduction pathway. Membrane targeting of PI 3-kinase is sufficient to activate PKB, which in turn has been shown to phosphorylate glycogen synthase kinase-3 by an ERK-independent pathway [20] . The constitutive activation of PI 3-kinase appears to downregulate the basal activity of ERKs, suggesting that PI(3,4,5)-P 3 may have an Membrane targeting of PI 3-kinase coincides with elevated basal phosphorylation of p47 phox . Serum-starved GM-1 and GM-128 cells were labeled with [ 32 P]orthophosphate. Where indicated 150 nM wortmannin (or vehicle) was added for 30 min before proteins were precipitated with 10 % trichloroacetic acid. Immunoprecipitates of p47 phox from renatured lysates were resolved by SDS-PAGE and blotted onto PVDF membranes; the 32 P content was determined using a PhosphorImager (Molecular Dynamics). After autoradiography, the membranes were rehydrated and the p47 phox content of each precipitate was estimated from western blots. Results from two independent experiments were normalized for p47 phox content. Mean values of four determinations ± SD. 
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Wortmannin inhibitory function in this pathway. In addition, membrane-targeting of PI 3-kinase implicates PI(3,4,5)-P 3 in the rapid phosphorylation of p47 phox , and hence in the physiological assembly of the NADPH oxidase.
Materials and methods

Materials
Cell culture media and antibiotics were purchased from GIBCO, Basel Switzerland; [ 32 P]␥ATP and [ 32 P]orthophosphate were from Amersham, UK; 17-hydroxywortmannin [10, 52] was a generous gift from T. Payne.
Antibodies
Anti-p85 serum was prepared from a rabbit that was immunized with purified recombinant human p85␣ (S.A.D. and M.T., unpublished observations). Anti-HA (12CA5) was from Boehringer Mannheim, Germany; alkaline phosphatase-and peroxidase-conjugated goat antirabbit antibodies were from Bio Rad, Switzerland; anti-ERK antibodies were from Santa Cruz Biotechnology, Santa Cruz, California, USA. Anti-p47 phox antibodies were a generous gift from O.T.G Jones.
Cell culture and transfections
The HA epitope with the amino-acid sequence YPYDVPDYASL was added to the amino terminus of the gene encoding p110␣, which was cloned from a human aorta cDNA library (to make HA-p110); for membrane targeting, the carboxyl terminus of Ha-Ras [16] , NPPDES-GPGCMSCKCVLS, was enclosed just before the stop codon (making HA-p110CAAX). The mutation of arginine 916 to proline (R916P) was produced by PCR-directed mutagenesis. Constructs were inserted downstream of the strong CMV1E1-promoter in the pcDNA3 expression vector which confers G418 resistance [34, 53] . GM-1 cells were cultured in RPMI-1640 supplemented with 10 % FCS [36] . Stable transfectants (GM-128) were obtained after electroporation of the corresponding vector and selection with 0.8 mg ml -1 G418. When indicated, cells were starved overnight in RPMI-1640 supplemented with 0.1 % FCS. For transient transfection, 18 g of plasmid DNA (HA-p110, HA-p110CAAX) was added together with 50 l lipofectamine (GIBCO) in 3 ml Optimem 1 medium (GIBCO) to 10 6 NIH-3T3 cells plated on 10 cm dishes. After 5 h at 37°C, 3 ml of DMEM containing 20 % FCS was added and the incubation continued for 24 h. The cells were then replated in 10 % FCS and cultured overnight. The transfection efficiency was moderate, but similar expression levels were found for all transfectants (about 10 % efficiency) and was estimated from immunofluorescence and western blots.
Cell fractionation and immunoprecipitations
Both GM-1 and NIH-3T3 cells were washed with PBS, sonicated on ice in 2.5 ml lysis buffer (50 mM NaCl, 1 mM EDTA, 1 mM DTT, 50 mM Tris-Cl (pH 8), complete protease inhibitors (Boehringer Mannheim) and 100 M PMSF) and the homogenates (more than 98 % broken cells) were centrifuged for 10 min at 100 000 rpm (TL-100, Beckman Instruments). Triton X-100 (1 %) was added to the supernatants, and the crude membrane pellets were solubilized in RIPA buffer (1 % Triton X-100, 1 % deoxycholate, 0.1 % SDS, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 20 mM Tris-Cl (pH 8) and protease inhibitors). Immunoprecipitations were performed as previously described [54] . Briefly, lysates were incubated for 20 min at 4°C with GammaBind G Sepharose (Pharmacia). Following centrifugation, the supernatants were incubated for 90 min at 4°C with the appropriate antibodies and the immunocomplexes were recovered by adding fresh GammaBind G Sepharose (Pharmacia) for an additional 30 min. For western blotting, the immunoprecipitates were washed once with RIPA buffer containing 0.5 M NaCl; twice with 0.15 M NaCl, 0.5 % NP-40, 0.5 % deoxycholate, 0.05 % SDS and 10 mM Tris-Cl (pH 8); and once with 0.05 % SDS and 10 mM Tris-Cl (pH 8). Western blots were performed as described [54] and developed with alkaline phosphataseconjugated goat anti-rabbit antibodies according to the instructions provided by the manufacturer.
Kinase assays PI 3-kinase activity was measured in either anti-p85 (IP p85) or anti-HA (IP HA) immunoprecipitates as described [55, 56] . Briefly, immunoprecipitates were washed at 4°C once with RIPA buffer; once with 0. . PI(3) 32 P was determined from the TLC plates using a PhosphorImager (Molecular Dynamics).
PKB activity was assessed in lysates of transiently transfected NIH-3T3 fibroblasts as previously described [19, 20, 39] . 10 cm dishes of confluent cultures were serum-starved overnight, washed twice with PBS and lysed in 300 l lysis buffer (50 mM Tris-Cl (pH 7.5), 1 % NP-40, 120 mM NaCl, 1 mM EDTA, 50 mM NaF, 40 mM ␤-glycerophosphate, 0.1 mM Na 3 VO 4 , 0.5 mM PMSF 1 mM benzamidine and 100 nM okadaic acid). From each lysate three aliquots (100 g protein) were precleared with Pansorbin (Calbiochem) and the endogenous PKB was immunoprecipitated with an affinity-purified rabbit antibody specific for the conserved carboxyl terminus (anti-RAC 469-480 [19] ) coupled to protein A-Sepharose (Pharmacia). Immunoprecipitates were washed once with lysis buffer containing 0.5 M NaCl; once with lysis buffer; and once with kinase buffer (50 mM Tris-Cl (pH 7.5), 1 mM DTT, 0.5 mM PMSF, 1 mM benzamidine and 100 nM okadaic acid). Immunoprecipitates were resuspended in 45 l kinase assay buffer containing 30 M peptide substrate (GRPRTSSFAEG derived from glycogen synthase kinase-3 [20] ), 1 M protein kinase A inhibitor (20-amino-acid peptide representing the active site of PKA, Bachem) and 10 mM MgCl 2 . Samples were prewarmed for 5 min at 30°C. Reactions were initiated by the addition of 5 l ATP (50 M ATP containing 2 Ci [ 32 P]␥ATP), and terminated after 30 min with 5 l 200 mM EDTA. From the reaction supernatants two aliquots of 20 l were spotted onto phosphocellulose paper, air-dried, washed four times with 1 % phosphoric acid and subjected to Cerenkov counting.
Cell labelling and phosphorylations
Serum-starved cells (2 × 10 6 ) were labeled with 0.2 mCi ml -1 [ 32 P]orthophosphate in 400 l of phosphate-free RPMI-1640 in 24-well plates for 80 min at 37°C. Serum (50 % in phosphate-free RPMI-1640), wortmannin (1 M in PBS and 0.01 % DMSO) or medium alone (total volume of the additions 100 l) were added for the indicated times, and the incubations were terminated with 220 l 4.8 M HCl and 2 mM DTT. Precipitated material and culture supernatants were transferred to polypropylene tubes, diluted with 1.28 ml CH 3 OH and sonicated until all material was finely dispersed. Samples were split in half and both aliquots were processed independently, as described elsewhere [56] . Briefly, lipids were extracted by the addition of 1. [55] and autoradiograms quantified using a PhosphorImager (Molecular Dynamics). The authenticity of PI(3,4,5)-P 3 was verified as follows. Lipids were scraped off the TLC plate, extracted with CHCl 3 :CH 3 OH (2:1, v/v), dried under vacuum, and deacylated with methylamine reagent at 53°C for 40 min as previously described [57] . Glyceroinositides were analyzed either by HPLC on Partisphere Sax columns [10] or by chromatography on polyethyleneimine-cellulose TLC plates in 0.44 M HCl [58] . Standards of 3-phosphorylated (glycero)phosphoinositides were prepared from pure PI precursors (Sigma) and phosphorylated with purified human PI 3-kinase [10] in the presence of [ 32 P]␥ATP.
HPLC analysis of deacylated phosphoinositides was performed as follows: serum-starved cells (2 × 10 6 ) were labeled with 0.3 mCi ml -1 [ 32 P]orthophosphate and lipids extracted as described above. Total lipids were deacylated with 300 l methylamine reagent at 53°C for 40 min [57] . The resulting glyceroinositides were dissolved in 50 l 20 mM NaH 2 PO 4 and separated by HPLC on a Partisphere Sax column [10] . The [ 32 P] content of each fraction was determined by liquid scintillation counting.
For the determination of p47 phox phosphorylation, serum-starved GM-1 and GM-128 cells (2 × 10 7 for each condition) were labeled in 900 l phosphate-free RPMI-1640 with 0.5 mCi ml -1 [ 32 P]orthophosphate for 70 min. Proteins were precipitated with trichloroacetic acid (10 % final concentration). The pellets were washed twice with acetone, air-dried, and solubilized in 150 l of 1 % SDS and 20 mM Tris-Cl (pH 8.0) at 95°C. The clear solutions were diluted with 1.5 ml of 1 % Triton X-100, 0.5 % Na-cholate, 150 mM NaCl, 1 mM EDTA, 0.1 mM Na 3 VO 4 , 20 mM NaF and 30 mM ␤-glycerophosphate, and renatured as described [54] . Immunoprecipitates of p47 phox were resolved by SDS-PAGE, blotted onto PVDF membranes and exposed to PhosphorImager screens. After autoradiography, the membranes were rehydrated and the p47 phox in each precipitate was estimated from western blots using peroxidase-conjugated goat anti-rabbit antibodies.
